Drug Discovery
The latest addition to the NovoCyte family, the NovoCyte Opteon, celebrates a decade of flow cytometry excellence
| 1 min read
The new platform helped UC San Diego scientists synthesize 32 potential multi-target cancer drugs
| 3 min read
Researchers leverage a new AI model, SyntheMol, which creates recipes for chemists to synthesize drugs
| 3 min read
Novel AI model, SyntheMol, generates billions of inexpensive antibiotic molecules targeting drug-resistant bacteria
| 2 min read
Research on protein evolution reveals new starting points for the rapid and targeted development of future drugs
| 2 min read
The SemaCyte Multiplexing Platform is an expansion of an existing platform that enables new features for drug discovery
| 2 min read
Techniques that are streamlining the drug discovery pipeline, enhancing efficiency and accuracy
| 2 min read
Innovative platform helps design molecules that can target helicases involved in numerous diseases
| 2 min read
Researchers develop novel method to predict the morphology of sugar coats on clinically relevant proteins within minutes
| 2 min read
Findings suggest placement of molecular linkers should be determined earlier on in drug discovery
| 3 min read
